REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 126 filers reported holding REVOLUTION MEDICINES INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,255 | -26.0% | 1,023 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $27,365 | +23.5% | 1,023 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $22,158 | -9.1% | 1,023 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $24,368 | +21.8% | 1,023 | 0.0% | 0.01% | +20.0% |
| Q3 2022 | $20,000 | 0.0% | 1,023 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $20,000 | -23.1% | 1,023 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $26,000 | 0.0% | 1,023 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $26,000 | -7.1% | 1,023 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $28,000 | -12.5% | 1,023 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $32,000 | – | 1,023 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 685,011 | $13,508,000 | 35.31% |
| TRV GP III, LLC | 3,604,130 | $71,073,000 | 31.03% |
| Nextech Invest Ltd. | 4,189,529 | $82,618,000 | 26.68% |
| Column Group LLC | 4,577,840 | $90,275,000 | 19.98% |
| Ponoi Management, LLC | 685,011 | $13,508,000 | 18.44% |
| TRV GP IV, LLC | 1,419,900 | $28,000,000 | 16.36% |
| Boxer Capital, LLC | 3,984,264 | $78,570,000 | 4.42% |
| Casdin Capital, LLC | 2,522,300 | $49,740,000 | 3.27% |
| Cormorant Asset Management, LP | 1,995,066 | $39,343,000 | 2.75% |
| BVF INC/IL | 3,255,588 | $64,200,000 | 2.65% |